Microencapsulation	NN
of	IN
lefty-secreting	NN
engineered	VBN
cells	NNS
for	IN
pulmonary	JJ
fibrosis	NN
therapy	NN
in	IN
mice	NNS
.	.

UNASSIGNED	NNP
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
disease	NN
that	WDT
causes	VBZ
unremitting	JJ
deposition	NN
of	IN
extracellular	JJ
matrix	NN
proteins	NNS
,	,
thus	RB
resulting	VBG
in	IN
distortion	NN
of	IN
the	DT
pulmonary	JJ
architecture	NN
and	CC
impaired	JJ
gas	NN
exchange	NN
.	.

Associated	VBN
with	IN
high	JJ
morbidity	NN
and	CC
mortality	NN
,	,
IPF	NN
is	VBZ
generally	RB
refractory	JJ
to	TO
current	JJ
pharmacological	JJ
therapies	NNS
.	.

Lefty-A	NNP
,	,
a	DT
potent	JJ
inhibitor	NN
of	IN
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
signaling	NN
,	,
has	VBZ
been	VBN
shown	VBN
to	TO
have	VB
promising	JJ
antifibrotic	JJ
ability	NN
in	FW
vitro	FW
for	IN
the	DT
treatment	NN
of	IN
renal	JJ
fibrosis	NN
and	CC
other	JJ
potential	JJ
organ	NN
fibroses	NNS
.	.

Here	RB
,	,
we	PRP
determined	VBD
if	IN
Lefty-A	NN
can	MD
attenuate	VB
bleomycin	NN
(	(
BLM	NN
)	)
-	:
induced	VBN
pulmonary	JJ
fibrosis	NN
in	FW
vivo	FW
based	VBN
on	IN
a	DT
novel	JJ
therapeutic	JJ
strategy	NN
where	WRB
HEK293	NN
cells	NNS
are	VBP
genetically	RB
engineered	VBN
with	IN
the	DT
Lefty-A-associated	JJ
GFP	NN
gene	NN
.	.

The	DT
engineered	VBN
HEK293	NN
cells	NNS
were	VBD
encapsulated	VBN
in	IN
alginate	JJ
microcapsules	NNS
and	CC
then	RB
subcutaneously	RB
implanted	VBN
in	IN
ICR	NN
mice	NNS
that	WDT
had	VBD
one	CD
week	NN
earlier	RB
been	VBN
intratracheally	RB
administered	VBN
BLM	NNP
to	TO
induce	VB
pulmonary	JJ
fibrosis	NN
.	.

The	DT
severity	NN
of	IN
fibrosis	NN
in	IN
lung	NN
tissue	NN
was	VBD
assessed	VBN
using	VBG
pathological	JJ
morphology	NN
and	CC
collagen	NN
expression	NN
to	TO
examine	VB
the	DT
effect	NN
of	IN
Lefty-A	NN
released	VBN
from	IN
the	DT
microencapsulated	VBN
cells	NNS
.	.

The	DT
engineered	VBN
HEK293	NN
cells	NNS
with	IN
Lefty-A	NN
significantly	RB
reduced	VBD
the	DT
expression	NN
of	IN
connective-tissue-growth-factor	NN
(	(
CTGF	NN
)	)
and	CC
type	NN
I	CD
collagen	NN
messenger	NN
mRNA	NN
,	,
lessened	VBD
the	DT
morphological	JJ
fibrotic	JJ
effects	NNS
induced	VBN
by	IN
bleomycin	NN
,	,
and	CC
increased	VBD
the	DT
expression	NN
of	IN
matrix	NN
metalloproteinase	NN
(	(
MMP	NN
)	)
-9	CD
.	.

This	DT
illustrates	VBZ
that	IN
engineered	VBN
HEK293	NN
cells	NNS
with	IN
Lefty-A	NN
can	MD
attenuate	VB
pulmonary	JJ
fibrosis	NN
in	FW
vivo	FW
,	,
thus	RB
providing	VBG
a	DT
novel	JJ
method	NN
to	TO
treat	VB
human	JJ
pulmonary	JJ
fibrotic	JJ
disease	NN
and	CC
other	JJ
organ	NN
fibroses	NNS
.	.

